External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX Trial

The ADA (Age–D-dimer–Albumin) score was developed to identify hospitalized patients at an increased risk for thrombosis in the coronavirus infectious disease-19 (COVID-19) setting. The study aimed to validate the ADA score for predicting thrombosis in a non-COVID-19 medically ill population from the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Gerald, Violi, Francesco, Pignatelli, Pasquale, Vestri, Annarita, Spagnoli, Alessandra, Loffredo, Lorenzo, Hernandez, Adrian F., Hull, Russell D., Cohen, Alexander T., Harrington, Robert A., Goldhaber, Samuel Z., Gibson, C. Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789884/
https://www.ncbi.nlm.nih.gov/pubmed/36566304
http://dx.doi.org/10.1007/s11239-022-02757-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789884/
https://www.ncbi.nlm.nih.gov/pubmed/36566304
http://dx.doi.org/10.1007/s11239-022-02757-8

Ejemplares similares